
ImaCor
Stage
Series A | AliveTotal Raised
$5.5MLast Raised
$5.5M | 15 yrs agoAbout ImaCor
ImaCor designs, manufactures, and distributes hTEE technology, the first and only critical care solution enabling clinicians to optimize cardiac performance with continuously-available, direct cardiac visualization over time, collectively serving patients, clinicians, and hospital administrators with the best possible clinical outcomes and cost-effective resource utilization. hTEE technology is enabled through the ZuraTM ultrasound systems and the miniaturized, disposable ClariTEE probe, uniquely designed to remain indwelling for up to 72 hours for episodic assessment of cardiac filling and function. Direct visualization with hTEE enables clinicians to optimize cardiac performance throughout a patient's course of treatment, allowing them to guide and assess the effectiveness of therapies, as well as make critical changes in management at the right time.
ImaCor Patents
ImaCor has filed 13 patents.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
11/7/2008 | 3/31/2015 | Transiting exoplanets, Triangle geometry, Cygnus (constellation), Geometric centers, Triangle centers | Grant |
Application Date | 11/7/2008 |
---|---|
Grant Date | 3/31/2015 |
Title | |
Related Topics | Transiting exoplanets, Triangle geometry, Cygnus (constellation), Geometric centers, Triangle centers |
Status | Grant |
Latest ImaCor News
Jun 30, 2022
The post Clarius Introduces Partnership with ImaCor That Powers New FDA Cleared Handheld Hemodynamic Ultrasound appeared first on NS Medical Devices.
ImaCor Frequently Asked Questions (FAQ)
Where is ImaCor's headquarters?
ImaCor's headquarters is located at 839 Stewart Av, Garden City.
What is ImaCor's latest funding round?
ImaCor's latest funding round is Series A.
How much did ImaCor raise?
ImaCor raised a total of $5.5M.
Who are the investors of ImaCor?
Investors of ImaCor include WFD Ventures and Johnson & Johnson Innovation.
Who are ImaCor's competitors?
Competitors of ImaCor include Pulsify Medical.
Compare ImaCor to Competitors

Dawako Medtech is developing bioimaging systems based on AI and wearable ultrasound imaging technology. It aims to make an impact in the field of ubiquitous monitoring and non-invasive, quantitative imaging biomarker analysis, facilitating decision-making for personalized healthcare. The company develops MIIXMED, an ultrasound imaging system that is hosted on a plug-in-oriented architecture. Dawako Medtech was founded in 2018 and is based in Paterna, Spain.
Pulsify Medical develops portable ultrasound monitoring pouches. It provides wearable ultrasound patches for non-invasive, real-time monitoring of physiological parameters inside the body. The company was founded in 2019 and is based in Leuven, Belgium.

Edwards Lifesciences (NYSE: EW) develops medical equipment and devices. It designs, manufactures, and markets tissue heart valves and related repair products. The company also provides solutions in enhanced surgical recovery, clot management, infection control, anesthesia, hospital administration, annuloplasty rings, catheters, hemodynamic monitoring, and more. It was founded in 1958 and is based in Irvine, California.

Getinge is a medical technology company. The company provides equipment, systems, operating rooms, and intensive-care units to the healthcare and the life science industries. The company also operates through the following businesses: Acute Care Therapies, Patient & Post-Acute Care, and Surgical Workflows.